Archived | Lexington’s SynapDx gets $2m as it looks to develop new autism test & Press Releases | Circa February 21, 2013 #NotAnAutisticAlly AGRE Collection

SynapDx logo Lexington’s SynapDx gets $2m as it looks to develop new autism test By Chris Reidy | Boston.com SynapDx Corp., a Lexington firm developing diagnostics for the earlier detection of autism, said Thursday that it has gotten $2 million in funding from Laboratory Corporation of America Holdings, or LabCorp, a North Carolina-based company that specializes …

Archived | Autism Speaks: Autism Treatment Network | Circa 2007 #NotAnAutisticAlly

Image: Human head and shoulders silhouette with Not An Autistic Ally text and the logo for Autism Speaks Autism Treatment Network (ATN). Interactive autism network (ian) Autism Treatment Network (ATN) Autism INtervention Research Network on Physical Health Autism Treatment Network What is the ATN?  The Autism Treatment Network (ATN) is a network of treatment and …

Archived | Autism Speaks: Clinical Trials Network | Circa 2007 #NotAnAutisticAlly

Clinical Trials Network Fluoxetine StudyMemantine Study Autism Speaks' Clinical Trials Network (CTN) was officially launched in 2005 by Cure Autism Now to focus on translational research, the critical step necessary to transfer findings from the laboratory to clinical application. Well controlled and appropriately blinded studies are needed to test whether anecdotal evidence holds. By facilitating …

Archived | Autism Speaks: New Developments In Autism Clinical Trials | Circa January 2004 #NotAnAutisticAlly

Download PDF d_200707_CANCONSENSUSDownload Jump to: New Developments in Autism Clinical Trials Outcome Measures for Clinical Drug Trials in Autism Subject Selection and Characterization in Clinical Trials in Children with Autism Impact of Recent Findings on Study Design of Future Autism Clinical Trials Autism Clinical Trials: Biological and Medical Issues in Patient Selection and Treatment Response …

Archived | Autism Speaks: New Study Shows Promise For Treatment Of Rett Syndrome | Circa February 8, 2007 #NotAnAutisticAlly

New Study Shows Promise for Treatment of Rett Syndrome  New research has found that the genetic mutation of the MeCP2 gene responsible for Rett Syndrome, an autism spectrum disorder, can be reversed pharmacologically in mice. The results of the experiments, conducted at the University of Edinburgh laboratories of Dr. Adrian Bird, were published Feb. 8, …

Archived | Autism Speaks: Autism Genome Project (AGP) | Circa 2004 #NotAnAutisticAlly

Autism Genome Project Launched in 2004, the Autism Genome Project, or AGP, is the largest study ever conducted to find the genes associated with inherited risk for autism. Many of the world's leading genetics researchers pooled their resources and used a promising new technology, the DNA microarray, to scan the human genome in the search for …

Archived | Autism Society Launches New State Resource Pages | Circa October 22, 2009 #NotAnAutisticAlly

(Links are original to the email and probably don’t work anymore.) Autism Society Now Accepting Donations through Amazon Payments The Autism Society is excited to announce that beginning this week we will be accepting Amazon Payments just in time for holiday giving, making it just as easy to donate as it is to shop on Amazon. The nation’s …